Adjuvant solution for pandemic influenza vaccine production
Christopher H. Clegg(TRIA Bioscience (United States)), Steven G. Reed(Infectious Disease Research Institute), Lucy A. Perrone(National Center for Immunization and Respiratory Diseases), Susan L. Baldwin(Seattle Children's Hospital), Joseph A. Rininger, Richard A. Bowen(Colorado State University), Richard Roque(TRIA Bioscience (United States)), Neal Van Hoeven(Sana Biotechnology (United States))
Cited by 73
Related Papers
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
|Nature Medicine|2007|1.4k
Key roles of adjuvants in modern vaccines
|Nature Medicine|2013|1.4k
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
|Science|2007|582
Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air
|Proceedings of the National Academy of Sciences|2009|224
Ecology of Zoonotic Infectious Diseases in Bats: Current Knowledge and Future Directions
|Zoonoses and Public Health|2012|206